drugset / Trial / NCT03480997

Acute Bronchodilator Effect of Inhaled Albuterol Sulfate and Ipratropium Bromide in Patients With Stable COPD

NCT03480997

Phase 1 Completed 46 enrolled Pneuma Respiratory, Inc
Non-randomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to demonstrate the pharmacodynamic bioequivalence of the test product to the reference product as measured by increases in FEV1.

Timeline

Start
2016-12-27
Primary completion
2017-04-28
Completion
2017-04-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Ipratropium Small molecule 20 ug Inhaled
Subject Salbutamol Unknown 100 ug Inhaled
Subject Salbutamol Unknown 200 ug Inhaled